These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15041886)

  • 1. [An organizational and economic approach in France to the ambulatory treatment of febrile neutropenia].
    Turlure P; Durand-Zaleski I
    Presse Med; 2004 Mar; 33(5):338-42. PubMed ID: 15041886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Outpatient antibiotherapy in children with neutropenia and fever. A review of the literature].
    Leverger G
    Presse Med; 2004 Mar; 33(5):330-7. PubMed ID: 15041885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment with oral antibiotics of febrile neutropenia in onco-haematology. The experience of the EORTC antimicrobial group].
    Cometta A; Kern W;
    Presse Med; 2004 Mar; 33(5):327-9. PubMed ID: 15041884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and economic considerations of empirical antibacterial therapy of febrile neutropenia in cancer.
    Dranitsaris G
    Pharmacoeconomics; 1999 Oct; 16(4):343-53. PubMed ID: 10623363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outpatient therapy for febrile neutropenia: clinical and economic implications.
    de Lalla F
    Pharmacoeconomics; 2003; 21(6):397-413. PubMed ID: 12678567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical and non-medical barriers to outpatient treatment of fever and neutropenia in children with cancer.
    Quezada G; Sunderland T; Chan KW; Rolston K; Mullen CA
    Pediatr Blood Cancer; 2007 Mar; 48(3):273-7. PubMed ID: 16435377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Application of the concepts of evidence-based medicine to the evidence on the treatment of febrile neutropenia].
    Jarque I; Sanz MA
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 2():95-102. PubMed ID: 10605194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The outpatient management of febrile neutropenia in cancer patients.
    Freifeld AG; Pizzo PA
    Oncology (Williston Park); 1996 Apr; 10(4):599-606, 611-2; discussion 615-6. PubMed ID: 8723296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily oral levofloxacin monotherapy versus piperacillin/tazobactam three times a day: a randomized controlled multicenter trial in patients with febrile neutropenia.
    Cornely OA; Wicke T; Seifert H; Bethe U; Schwonzen M; Reichert D; Ullmann AJ; Karthaus M; Breuer K; Salzberger B; Diehl V; Fätkenheuer G
    Int J Hematol; 2004 Jan; 79(1):74-8. PubMed ID: 14979482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
    Paganini H; Rodriguez-Brieshcke T; Zubizarreta P; Latella A; Firpo V; Casimir L; Armada A; Fernández C; Cáceres E; Debbag R
    Cancer; 2001 Apr; 91(8):1563-7. PubMed ID: 11301406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes].
    Cordonnier C; Leverger G; Schlemmer B; Andremont A; Boasson M; Herbrecht R; Kazmierczak A; Marie JP; Marit G; Miclea JM
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):289-91. PubMed ID: 7971247
    [No Abstract]   [Full Text] [Related]  

  • 12. Introduction to the Australian consensus guidelines for the management of neutropenic fever in adult cancer patients, 2010/2011. Australian Consensus Guidelines 2011 Steering Committee.
    Lingaratnam S; Slavin MA; Koczwara B; Seymour JF; Szer J; Underhill C; Prince M; Mileshkin L; O'Reilly M; Kirsa SW; Bennett CA; Davis ID; Morrissey O; Thursky KA;
    Intern Med J; 2011 Jan; 41(1b):75-81. PubMed ID: 21272171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient management of fever in children with sickle cell disease (SCD) in an African setting.
    Rahimy MC; Gangbo A; Ahouignan G; Anagonou S; Boco V; Alihonou E
    Am J Hematol; 1999 Sep; 62(1):1-6. PubMed ID: 10467269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New trends in patient management: risk-based therapy for febrile patients with neutropenia.
    Rolston KV
    Clin Infect Dis; 1999 Sep; 29(3):515-21. PubMed ID: 10530438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of febrile neutropenia episodes in children, with a piperacillin-tazobactam and netilmicin combination].
    Fouyssac F; Salmon A; Mansuy L; Schmitt C; Bordigoni P; Chastagner P
    Med Mal Infect; 2005 Jun; 35(6):357-62. PubMed ID: 15982848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patients.
    Teuffel O; Amir E; Alibhai S; Beyene J; Sung L
    Br J Cancer; 2011 Apr; 104(9):1377-83. PubMed ID: 21468048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin and amoxicillin as continuation treatment of febrile neutropenia in pediatric cancer patients.
    Park JR; Coughlin J; Hawkins D; Friedman DL; Burns JL; Pendergrass T
    Med Pediatr Oncol; 2003 Feb; 40(2):93-8. PubMed ID: 12461792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
    Paganini HR; Sarkis CM; De Martino MG; Zubizarreta PA; Casimir L; Fernandez C; Armada AA; Rodriguez-Brieshcke MT; Debbag R
    Cancer; 2000 Jun; 88(12):2848-52. PubMed ID: 10870071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a home intravenous antibiotic program in pediatric oncology.
    Wiernikowski JT; Rothney M; Dawson S; Andrew M
    Am J Pediatr Hematol Oncol; 1991; 13(2):144-7. PubMed ID: 1906246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.